TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CAPR

Capricor Therapeutics Inc

Healthcare · Biotechnology

9.40$ +10.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Capricor Therapeutics Inc (CAPR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.3% of the shares are freely tradable; institutional investors hold 59.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 59.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 9.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 78.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 42.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 58Mio.

Largest Shareholders

Institutions

Institutions CAPR
Name Stake (%) Shares Change (%) Date
Suvretta Capital Management, LLC 6.57 3,818,600 +113.9 03/31/2026
BlackRock Inc 5.89 3,421,815 +20.0 03/31/2026
TANG CAPITAL MANAGEMENT LLC 5.85 3,399,900 +100.0 03/31/2026
State Street Corp 3.75 2,181,901 +163.0 03/31/2026
Vanguard Capital Management, LLC 3.49 2,027,732 +0.0 03/31/2026
RA Capital Management, LLC 2.59 1,507,844 +0.0 03/31/2026
Geode Capital Management, LLC 1.92 1,118,326 +9.9 03/31/2026

Funds

Funds CAPR
Name Stake (%) Shares Change (%) Date
State Street® SPDR® S&P® Biotech ETF 3.94 2,292,060 -1.1 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.85 1,655,365 +0.0 07/31/2026
iShares Russell 2000 ETF 2.37 1,379,505 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?